Stock Ratings / Health Care / SBC / options

STLN (37) AHCO (45) SRTA (47) AUNA (61) ⌘ Pro Terminal →

SBC Medical Group Holdings Incorporated (SBC) Options Positioning, Max Pain & Unusual Sweeps

$5.69 +4.40% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

SBC Medical Group Holdings Incorporated (SBC) earns a Roarable Rating of B- (Buy) with 71/100 RQD Confidence. High-quality cash engine (73% profit margin, 63% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE B- • BUY Cap $585.2M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERBUY • B-

2-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk B-

Each axis scored 0–20

12M PRICE TARGET CONE+5.8% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for SBC)Realized 20D OHLCV Swing Band: ±10.6%

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±10.6%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (SBC)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for SBC.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating SBC & AI Leaders Without Chasing Tops

✓Institutional whale strikes & implied earnings move audit on SBC
✓How disciplined traders manage risk using pre-published trigger & invalidation levels
✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

SBC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +72.42%⚡ TESTING RESISTANCE

2026-10-30O $5.68H $5.70L $5.24C $5.69VOL 155.3K

RES: $5.89SUP: $2.99SMA50: $4.87SMA200: $3.91

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

SBC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 SBC Butterfly Map → + Track SBC →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

1.6%/yr Implied 5Y Growth

vs. -15.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on SBC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for SBC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for SBC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SBC)

Health Care Rank #87 of 1016 ⚔️ STLN vs SBC Full Matrix →

1. Head-to-Head Health Care Peer Comparison (SBC vs. STLN, AHCO, SRTA, AUNA)

Industry: Medical/Nursing Services (29 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, SBC Medical Group Holdings Incorporated (SBC) ranks #87 by composite RQD confidence (71/100, grade B-) and #425 by equity capitalization ($585.2M). Within this direct 5-issuer industry benchmark cohort, SRTA leads on earnings valuation at 10.2x trailing P/E, while SBC leads on capital efficiency and profitability with 63.1% ROIC and 73.3% gross margin. SBC currently leads its immediate peer cohort in composite quantitative strength at 71/100 (B-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
SBC ACTIVE SBC Medical Group Holdings Incorporated	B-	71/100	11.5x	73.3%	63.1%	+4.40%	$585.2M	Benchmark Subject
STLN Starling Oncology Inc.	D-	37/100	—	—	-35.0%	+0.15%	$677.7M	/stln-vs-sbc →
AHCO AdaptHealth Corp.	D	45/100	—	18.8%	2.2%	-1.66%	$808.5M	/ahco-vs-sbc →
SRTA Strata Critical Medical Inc. (Class A)	D	47/100	10.2x	20.9%	-7.1%	-0.21%	$420.2M	/srta-vs-sbc →
AUNA Auna SA (Class A)	C-	61/100	—	—	—	+1.27%	$355.3M	/auna-vs-sbc →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001930313

In its most recent audited fiscal period (FY2025, filed 2025-12-31), SBC Medical Group Holdings Incorporated (SBC) reported GAAP revenue of $173.6M (-15.5% vs. FY2024 revenue of $205.4M , and -10.3% cumulative change since FY2023) , GAAP net income of $51.0M, operating cash flow of $24.7M, and free cash flow of $23.3M (+29.1% YoY). On the balance sheet, SBC closed FY2025 with $380.4M in total assets against $0 in total debt (Altman Z-Score: 5.46, Piotroski F-Score: 6/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$173.6M	$51.0M	$24.7M	$23.3M	$380.4M	—
FY2024 (FY)	2024-12-31	$205.4M	$46.6M	$20.6M	$18.0M	$266.1M	—
FY2023 (FY)	2023-12-31	$193.5M	$39.4M	$50.7M	$50.7M	—	—

3. SBC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is SBC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, SBC Medical Group Holdings Incorporated (NASDAQ: SBC) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 71/100 at a spot price of $5.69 (+4.40% 1D, market cap $585.2M). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 16/20. Across 1016 tracked Health Care issuers, SBC ranks #87 in composite RQD confidence.

How does SBC compare to STLN and AHCO in the Health Care sector?

Within the Health Care sector (Medical/Nursing Services), SBC carries a Roarable B- (71/100 RQD), trailing P/E of 11.5x, gross margin of 73.3%, and ROIC of 63.1%. By comparison, STLN (Starling Oncology Inc.) holds a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $677.7M) and AHCO (AdaptHealth Corp.) posts a D grade (45/100 RQD, P/E N/A, ROIC 2.2%, cap $808.5M). Among the 5-stock peer group, SRTA leads on earnings multiple (10.2x) while SBC leads on capital efficiency (63.1% ROIC).

What are the biggest fundamental strengths and SEC risk factors for SBC?

Per SBC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001930313), SBC Medical Group Holdings Incorporated generated $173.6M in revenue (-15.5% YoY), $51.0M in net income, and $23.3M in free cash flow against $380.4M in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (73% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is SBC trading relative to its 50-day, 200-day, and 52-week technical levels?

SBC last traded at $5.69 (+4.40% on volume of 258,973 shares), positioning the stock +16.84% above its 50-day simple moving average ($4.87) and +45.52% above its 200-day simple moving average ($3.91). Across its 52-week range of $2.78 to $5.79, SBC sits at the 96.7% percentile with a 14-day RSI of 51.8 (NEUTRAL RANGE) and an implied next-earnings move of ±10.6% ($5.09 to $6.29).

SBC Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is SBC's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for SBC.

Direct Sub-Reports: SBC RQD Cockpit SBC 12M Forecast SBC Earnings & Move SBC Dividends & DRIP SBC Insiders & 13F SBC Whale Options SBC Profit Sankey SBC News & Why